Human protective response induced by meningococcus B vaccine is mediated by the synergy of multiple bactericidal epitopes
Abstract 4CMenB is the first broad coverage vaccine for the prevention of invasive meningococcal disease caused by serogroup B strains. To gain a comprehensive picture of the antibody response induced upon 4CMenB vaccination and to obtain relevant translational information directly from human studie...
Main Authors: | M. Giuliani, E. Bartolini, B. Galli, L. Santini, P. Lo Surdo, F. Buricchi, M. Bruttini, B. Benucci, N. Pacchiani, L. Alleri, D. Donnarumma, W. Pansegrau, I. Peschiera, I. Ferlenghi, R. Cozzi, N. Norais, M. M. Giuliani, D. Maione, M. Pizza, R. Rappuoli, O. Finco, V. Masignani |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2018-02-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-018-22057-7 |
Similar Items
-
The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology
by: Vega Masignani, et al.
Published: (2019-04-01) -
Immunological fingerprint of 4CMenB recombinant antigens via protein microarray reveals key immunosignatures correlating with bactericidal activity
by: E. Bartolini, et al.
Published: (2020-10-01) -
NadA3 Structures Reveal Undecad Coiled Coils and LOX1 Binding Regions Competed by Meningococcus B Vaccine-Elicited Human Antibodies
by: Alessia Liguori, et al.
Published: (2018-10-01) -
4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbp.
by: Daniele Veggi, et al.
Published: (2020-10-01) -
The Meningococcus : variability, antigenicity, and toxicity
by: Maegraith, Brian
Published: (1934)